Compounds > topotecan
Page last updated: 2024-08-24

topotecan and Lung Injury, Acute

topotecan has been researched along with Lung Injury, Acute in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, MZ; Hu, YB; Jin, JJ; Liu, HB; Lv, TF; Song, Y; Wan, B; Wang, XX; Xi, GM; Xu, WJ; Zhan, P; Zhang, XW; Zhu, SH1
Jin, J; Lv, T; Miao, Y; Song, Y; Wan, B; Wang, X; Xu, W; Zhou, Z1

Other Studies

2 other study(ies) available for topotecan and Lung Injury, Acute

ArticleYear
Topotecan alleviates ventilator-induced lung injury via NF-κB pathway inhibition.
    Cytokine, 2018, Volume: 110

    Topics: Acute Lung Injury; Animals; Apoptosis; Bronchoalveolar Lavage Fluid; Caspase 3; Cytokines; Disease Models, Animal; Epithelial Cells; Inflammation; Lung; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Peroxidase; Topotecan; Ventilator-Induced Lung Injury

2018
Topotecan Alleviates Lipopolysaccharide-Mediated Acute Lung Injury Via the NF-κB Signaling Pathway.
    The Journal of surgical research, 2019, Volume: 235

    Topics: Acute Lung Injury; Animals; Cells, Cultured; Cytokines; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; NF-kappa B; Signal Transduction; Topoisomerase I Inhibitors; Topotecan

2019